Skip to content

Belgian Infective Endocarditis Registry

Belgian Infective Endocarditis Registry

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06745440
Acronym
BIER
Enrollment
300
Registered
2024-12-20
Start date
2025-09-01
Completion date
2033-12-31
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective Endocarditis

Brief summary

The objective of this prospective observational registry is to study patients di-agnosed with infective endocarditis (IE) and to gather comprehensive long-term outcome data, including mortality rates and IE-related complications (e.g., thromboembolic events, (hospitalization for) heart failure, valve surgery and IE recurrence) at one, three-, and five-years post-enrollment. Additionally, the registry will document epidemiological characteristics, clinical presentation at baseline, biochemical and microbiological profiles, relevant comorbidities and risk factors, diagnostic strategies, and therapeutic interventions, including an-timicrobial therapy and surgical procedures.

Interventions

None listed

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\> 18 yo

Design outcomes

Primary

MeasureTime frame
Mortality5-years

Contacts

Primary ContactBram Roosens, MD, PhD.
bram.roosens@uzbrussel.be+32472581608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026